Skip to main content
Clinical Trials/ISRCTN46302353
ISRCTN46302353
Completed
未知

Dexmedetomidine versus propofol in awake implantation of neuromodulative systems

Erasmus Medical Center0 sites72 target enrollmentDecember 3, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic pain
Sponsor
Erasmus Medical Center
Enrollment
72
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31321763 results (added 16/01/2020)

Registry
who.int
Start Date
December 3, 2015
End Date
April 20, 2018
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged between 18 and 65 years.
  • 2\. Indication for implantation of a neuromodulative system

Exclusion Criteria

  • 1\. Hypersensitivity of active part of one of any of the excipients
  • 2\. AV\-blok (II or III)
  • 3\. Acute cerebrovascular disease
  • 4\. Pregnancy
  • 5\. Acute epilepsy
  • 6\. Severe liver dysfunction
  • 7\. Use of a beta blocker
  • 8\. Use of medications causing hypotension or bradycardia.
  • 9\. Psychologically unstable
  • 10\. Communication problem

Outcomes

Primary Outcomes

Not specified

Similar Trials